Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2017 (2017), Article ID 5763094, 8 pages
https://doi.org/10.1155/2017/5763094
Research Article

Interaction Effects of Season of Birth and Cytokine Genes on Schizotypal Traits in the General Population

Mental Health Research Center, Kashirskoe Shosse 34, Moscow 115522, Russia

Correspondence should be addressed to Margarita V. Alfimova; moc.liamg@avomifla.m

Received 15 August 2017; Accepted 13 December 2017; Published 31 December 2017

Academic Editor: Luis San

Copyright © 2017 Margarita V. Alfimova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Davies, J. Welham, D. Chant, E. F. Torrey, and J. McGrath, “A Systematic Review and Meta-analysis of Northern Hemisphere Season of Birth Studies in Schizophrenia,” Schizophrenia Bulletin, vol. 29, no. 3, pp. 587–593, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. T. L. Demler, “Challenging the Hypothesized link to season of birth in patients with Schizophrenia,” Innovations in Clinical Neuroscience, vol. 8, no. 9, pp. 14–19, 2011. View at Google Scholar · View at Scopus
  3. E. F. Torrey, R. R. Rawlings, J. M. Ennis, D. D. Merrill, and D. S. Flores, “Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths,” Schizophrenia Research, vol. 21, no. 3, pp. 141–149, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Kneeland and S. H. Fatemi, “Viral infection, inflammation and schizophrenia,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 42, pp. 35–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Meyer, J. Feldon, and B. K. Yee, “A review of the fetal brain cytokine imbalance hypothesis of schizophrenia,” Schizophrenia Bulletin, vol. 35, no. 5, pp. 959–972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Thysen, M. A. Rasmussen, E. Kreiner-Møller et al., “Season of birth shapes neonatal immune function,” The Journal of Allergy and Clinical Immunology, vol. 137, no. 4, pp. 1238–1246.e13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. M. L. Estes and A. K. McAllister, “Maternal immune activation: Implications for neuropsychiatric disorders,” Science, vol. 353, no. 6301, pp. 772–777, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Scola and A. Duong, “Prenatal maternal immune activation and brain development with relevance to psychiatric disorders,” Neuroscience, vol. 346, pp. 403–408, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Ratnayake, T. Quinn, D. W. Walker, and H. Dickinson, “Cytokines and the neurodevelopmental basis of mental illness,” Frontiers in Neuroscience, no. 7, Article ID 00180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. L. Rapoport, A. M. Addington, S. Frangou, and M. R. C. Psych, “The neurodevelopmental model of schizophrenia: update 2005,” Molecular Psychiatry, vol. 10, no. 5, pp. 434–449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. A. Jenkins, “Perinatal complications and schizophrenia: Involvement of the immune system,” Frontiers in Neuroscience, no. 7, Article ID Article 110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ayhan, R. McFarland, and M. V. Pletnikov, “Animal models of gene-environment interaction in schizophrenia: a dimensional perspective,” Progress in Neurobiology, vol. 136, pp. 1–27, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI), Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations, Schizophrenia Bulletin, vol. 40, no. 4, pp. 729–736, 2014.
  14. G. Modinos, C. Iyegbe, D. Prata et al., “Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review,” Schizophrenia Research, vol. 150, no. 2-3, pp. 356–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Barrantes-Vidal, G. M. Gross, T. Sheinbaum, M. Mitjavila, S. Ballespí, and T. R. Kwapil, “Positive and negative schizotypy are associated with prodromal and schizophrenia-spectrum symptoms,” Schizophrenia Research, vol. 145, no. 1–3, pp. 50–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Barrantes-Vidal, P. Grant, and T. R. Kwapil, “The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders,” Schizophrenia Bulletin, vol. 41, pp. S408–S416, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. E. E. Walter, F. Fernandez, M. Snelling, and E. Barkus, “Genetic consideration of schizotypal traits: A review,” Frontiers in Psychology, vol. 7, article no. 1769, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Ettinger, I. Meyhöfer, M. Steffens, M. Wagner, and N. Koutsouleris, “Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia,” Frontiers in Psychiatry, vol. 5, article 18, 2014. View at Publisher · View at Google Scholar
  19. O. J. Mason, “The assessment of schizotypy and its clinical relevance,” Schizophrenia Bulletin, vol. 41, 2, pp. S374–S385, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. H. Fanous, M. C. Neale, C. O. Gardner et al., “Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy,” Molecular Psychiatry, vol. 12, no. 10, pp. 958–965, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. K. Bolinskey, C. A. Iati, H. K. Hunter, and J. H. Novi, “Season of birth, mixed-handedness, and psychometric schizotypy: Preliminary results from a prospective study,” Psychiatry Research, vol. 208, no. 3, pp. 210–214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Cohen and G. M. Najolia, “Birth characteristics and schizotypy: evidence of a potential 'second hit',” Journal of Psychiatric Research, vol. 45, no. 7, pp. 955–961, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Hori, T. Teraishi, D. Sasayama et al., “Relationships between season of birth, schizotypy, temperament, character and neurocognition in a non-clinical population,” Psychiatry Research, vol. 195, no. 1-2, pp. 69–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Konrath, D. Beckius, and U. S. Tran, “Season of birth and population schizotypy: results from a large sample of the adult general population,” Psychiatry Research, vol. 242, pp. 245–250, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Córdova-Palomera, R. Calati, B. Arias et al., “Season of birth and subclinical psychosis: Systematic review and meta-analysis of new and existing data,” Psychiatry Research, vol. 225, no. 3, pp. 227–235, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Raine, “The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria,” Schizophrenia Bulletin, vol. 17, no. 4, pp. 555–564, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Arrode-Brusés and J. L. Brusés, “Maternal immune activation by poly(I:C) induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain,” Journal of Neuroinflammation, vol. 9, article 83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. H. Dimitrov, S. Lee, J. Yantis, C. Honaker, and N. Braida, “Cytokine serum levels as potential biological markers for the Psychopathology in Schizophrenia,” Advances in Psychiatry, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  29. B. J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick, “Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects,” Biological Psychiatry, vol. 70, no. 7, pp. 663–671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. V. E. Golimbet, G. I. Korovaĭtseva, M. V. Gabaeva et al., “A study of IL-1Β and IDO gene polymorphisms in patients with schizophrenia,” Zhurnal of Nevrologii i Psikhiatrii Im S S Korsakova, vol. 114, no. 5, pp. 46–49, 2014. View at Publisher · View at Google Scholar
  31. P. Kapelski, M. Skibinska, M. Maciukiewicz et al., “An Association Between Functional Polymorphisms of the Interleukin 1 Gene Complex and Schizophrenia Using Transmission Disequilibrium Test,” Archivum Immunologiae et Therapia Experimentalis, vol. 64, pp. 161–168, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. B. H. Shirts, J. Wood, R. H. Yolken, and V. L. Nimgaonkar, “Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1β,” Schizophrenia Research, vol. 88, no. 1-3, pp. 235–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Xu and L. He, “Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population,” Schizophrenia Research, vol. 120, no. 1-3, pp. 131–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Fatjó-Vilas, E. Pomarol-Clotet, R. Salvador et al., “Effect of the interleukin-1β gene on dorsolateral prefrontal cortex function in schizophrenia: A genetic neuroimaging study,” Biological Psychiatry, vol. 72, no. 9, pp. 758–765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. M. Meisenzahl, D. Rujescu, A. Kirner et al., “Association of an interleukin-1β genetic polymorphism with altered brain structure in patients with schizophrenia,” The American Journal of Psychiatry, vol. 158, no. 8, pp. 1316–1319, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Papiol, V. Molina, A. Rosa, J. Sanz, T. Palomo, and L. Fañanás, “Effect of interleukin-1β gene functional polymorphism on dorsolateral prefrontal cortex activity in schizophrenic patients,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 144, no. 8, pp. 1090–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. D. F. Levinson, M. D. Levinson, R. Segurado, and C. M. Lewis, “Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis,” American Journal of Human Genetics, vol. 73, no. 1, pp. 17–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Méndez-Samperio, A. Badillo-Flores, A. Nuñez-Vazquez, and M. Hernandez Garay, “Interleukin-4 inhibits secretion of interleukin-1β in the response of human cells to mycobacterial heat shock proteins,” Clinical and Diagnostic Laboratory Immunology, vol. 4, no. 6, pp. 665–670, 1997. View at Google Scholar · View at Scopus
  39. H. Park, H. Shim, K. An, A. Starkweather, K. S. Kim, and I. Shim, “IL-4 Inhibits IL-1,” Mediators of Inflammation, vol. 2015, Article ID 941413, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  40. S. Sone, E. Orino, K. Mizuno et al., “Production of IL-1 and its receptor antagonist is regulated differently by IFN-γ and IL-4 in human monocytes and alveolar macrophages,” European Respiratory Journal, vol. 7, no. 4, pp. 657–663, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Dewberry, H. Holden, D. Crossman, and S. Francis, “Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 11, pp. 2394–2400, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. L. J. Rosenwasser, D. J. Klemm, J. K. Dresback et al., “Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy,” Clinical & Experimental Allergy, vol. 25, supplement 2, pp. 74–78, 1995. View at Publisher · View at Google Scholar · View at Scopus
  43. W. J. Gauderman, “Sample size requirements for association studies of gene-gene interaction,” American Journal of Epidemiology, vol. 155, no. 5, pp. 478–484, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Cauci, M. Di Santolo, K. K. Ryckman, S. M. Williams, and G. Banfi, “Variable number of tandem repeat polymorphisms of the interleukin-1 receptor antagonist gene IL-1RN: A novel association with the athlete status,” BMC Medical Genetics, vol. 11, no. 1, article no. 29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Psachoulia, K. A. Chamberlain, D. Heo et al., “IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation,” Brain, vol. 139, no. 12, pp. 3121–3136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. J. T. Walsh, S. Hendrix, F. Boato et al., “MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4,” The Journal of Clinical Investigation, vol. 125, no. 2, pp. 699–714, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. S. P. Gadani, J. C. Cronk, G. T. Norris, and J. Kipnis, “IL-4 in the brain: a cytokine to remember,” The Journal of Immunology, vol. 189, no. 9, pp. 4213–4219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. Z. Li, F. Liu, H. Ma et al., “Age exacerbates surgery-induced cognitive impairment and neuroinflammation in Sprague-Dawley rats: the role of IL-4,” Brain Research, vol. 1665, pp. 65–73, 2017. View at Publisher · View at Google Scholar
  49. O. S. Von Ehrenstein, G. I. Neta, W. Andrews, R. Goldenberg, A. Goepfert, and J. Zhang, “Child intellectual development in relation to cytokine levels in umbilical cord blood,” American Journal of Epidemiology, vol. 175, no. 11, pp. 1191–1199, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Liu, J. Liu, S. Zhao et al., “Interleukin-4 is essential for microglia/macrophage M2 polarization and long-term recovery after cerebral ischemia,” Stroke, vol. 47, no. 2, pp. 498–504, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Mori, P. Maher, and B. Conti, “Neuroimmunology of the Interleukins 13 and 4,” Brain Sciences, vol. 6, no. 2, article 18, 2016. View at Publisher · View at Google Scholar
  52. J. Yang, S. Ding, W. Huang et al., “Interleukin-4 ameliorates the functional recovery of intracerebral hemorrhage through the alternative activation of microglia/macrophage,” Frontiers in Neuroscience, vol. 10, article no. 61, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Tochigi, Y. Okazaki, N. Kato, and T. Sasaki, “What causes seasonality of birth in schizophrenia?” Neuroscience Research, vol. 48, no. 1, pp. 1–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. N. H. A. Suaini, Y. Zhang, P. J. Vuillermin, K. J. Allen, and L. C. Harrison, “Immune modulation by vitamin D and its relevance to food allergy,” Nutrients, vol. 7, no. 8, pp. 6088–6108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Wrzosek, J. Lukaszkiewicz, M. Wrzosek et al., “Vitamin D and the central nervous system,” Pharmacological Reports, vol. 65, no. 2, pp. 271–278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Boonstra, F. J. Barrat, C. Crain, V. L. Heath, H. F. J. Savelkoul, and A. O'Garra, “1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+T cells to enhance the development of Th2 cells,” The Journal of Immunology, vol. 167, no. 9, pp. 4974–4980, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Calvello, A. Cianciulli, G. Nicolardi et al., “Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses,” Journal of Neuroimmune Pharmacology, vol. 12, no. 2, pp. 327–339, 2017. View at Publisher · View at Google Scholar · View at Scopus
  58. B. D. Mahon, A. Wittke, V. Weaver, and M. T. Cantorna, “The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells,” Journal of Cellular Biochemistry, vol. 89, no. 5, pp. 922–932, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. J. J. McGrath, D. W. Eyles, C. B. Pedersen et al., “Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study,” Archives of General Psychiatry, vol. 67, no. 9, pp. 889–894, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. G. C. Man, T. Zhang, X. Chen et al., “The regulations and role of circadian clock and melatonin in uterine receptivity and pregnancy-An immunological perspective,” American Journal of Reproductive Immunology, vol. 78, no. 2, Article ID e12715, 2017. View at Publisher · View at Google Scholar
  61. W. Ren, G. Liu, S. Chen et al., “Melatonin signaling in T cells: functions and applications,” Journal of Pineal Research, vol. 62, no. 3, 2017. View at Publisher · View at Google Scholar
  62. I.-S. Shin, J.-W. Park, N.-R. Shin et al., “Melatonin reduces airway inflammation in ovalbumin-induced asthma,” Immunobiology, vol. 219, no. 12, pp. 901–908, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. T. da Silva Araújo, A. J. Maia Chaves Filho, A. S. Monte et al., “Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs,” Journal of Psychiatric Research, vol. 84, pp. 49–58, 2017. View at Publisher · View at Google Scholar · View at Scopus
  64. C. C. H. Lin, C.-H. Su, P.-H. Kuo, C. K. Hsiao, W.-T. Soong, and W. J. Chen, “Genetic and environmental influences on schizotypy among adolescents in Taiwan: a multivariate twin/sibling analysis,” Behavior Genetics, vol. 37, no. 2, pp. 334–344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. M. Linney, R. M. Murray, E. R. Peters, A. M. MacDonald, F. Rijsdijk, and P. C. Sham, “A quantitative genetic analysis of schizotypal personality traits,” Psychological Medicine, vol. 33, no. 5, pp. 803–816, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. S. E. Morton, K. J. O’Hare, J. L. Maha et al., “Testing the validity of taxonic schizotypy using genetic and environmental risk variables,” Schizophrenia Bulletin, vol. 43, pp. 633–643, 2017. View at Publisher · View at Google Scholar
  67. P. H. Venables, “Schizotypy and maternal exposure to influenza and to cold temperature: the Mauritius study,” Journal of Abnormal Psychology, vol. 105, no. 1, pp. 53–60, 1996. View at Publisher · View at Google Scholar · View at Scopus